The cyclins: a family of widely expressed tumor antigens?

Authors: von Bergwelt-Baildon, Michael S; Kondo, Eisei; Klein-Gonzáález, Nela; Wendtner, Clemens M

Source: Expert Review of Vaccines, 1 March 2011, vol. 10, no. 3, pp. 389-395(7)

Publisher:

Buy & download fulltext article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Abstract:

Continuous cell division is a hallmark of cancer and cell-cycle regulators therefore represent relevant target molecules for tumor therapy. Among these targets the cyclins are of particular interest as they are overexpressed in various tumor entities with little expression in normal tissue. Here we review evidence that these molecules are recognized by the immune system, summarize why cyclins A, B and D in particular appear to be interesting targets for active and passive immunotherapy, and discuss whether the entire family could be an interesting novel class of tumor antigens for cancer treatment and prevention.

Keywords: T-cell epitopes; active immunotherapy; cyclin; tumor antigens

Document Type: Research Article

DOI: http://dx.doi.org/10.1586/erv.10.170

Publication date: March 1, 2011

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page